Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Efficacy of <i>Lacticaseibacillus rhamnosus</i> CRL 1505 in Preventing Upper Respiratory Tract Infections in Healthy Adults.

Microorganisms·2026
Same author

Nocebo effect in inhaler use: Patients' beliefs and treatment adherence.

Exploratory research in clinical and social pharmacy·2025
Same author

Anemia in COPD and cardiovascular mortality.

Respiratory medicine·2025
Same author

Gene Expression Profiles Reveal Distinct Mechanisms Driving Chronic Obstructive Pulmonary Disease Exacerbations.

International journal of molecular sciences·2025
Same author

The Impact of Anemia on Long-Term Mortality in Hospitalized Patients with Exacerbation of Chronic Obstructive Pulmonary Disease.

International journal of chronic obstructive pulmonary disease·2024
Same author

Hydrogen Peroxide in Pleural Fluid, a Rapid Test for Differentiating Transudates and Exudates.

Archivos de bronconeumologia·2024

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
05:56

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis

Published on: August 9, 2024

2.4K

Mortality Prediction in Hospitalized COPD Patients Based on FEV1/FVC Severity Staging.

Eduardo Garcia-Pachon1,2, Lucia Zamora-Molina1,2, Carlos Baeza-Martinez1,2

  • 1Section of Respiratory Medicine, Hospital General Universitario de Elche, 03203 Elche, Spain.

Journal of Clinical Medicine
|November 13, 2025
PubMed
Summary

The Staging of Airflow Obstruction by Ratio (STAR) system effectively predicts mortality in hospitalized COPD patients from grades 2-4. However, STAR grade 1 did not differentiate lower-risk patients, suggesting potential underestimation of severity.

Keywords:
GOLDchronic obstructive pulmonary diseasehospitalizationmortalityprognosisseverity of illness index

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

517
Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging
10:44

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

1.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
05:56

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis

Published on: August 9, 2024

2.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

517
Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging
10:44

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

1.0K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Epidemiology

Background:

  • The Staging of Airflow Obstruction by Ratio (STAR) system uses FEV1/FVC ratio for COPD severity classification.
  • STAR aims to improve prognostic performance compared to existing systems like GOLD.

Purpose of the Study:

  • To evaluate the prognostic performance of the STAR system in patients hospitalized for COPD exacerbation.
  • To compare the mortality prediction accuracy of STAR against the GOLD classification.

Main Methods:

  • Retrospective observational study of 197 COPD patients discharged after severe exacerbation.
  • Collected clinical, spirometric data, GOLD classification, STAR system, and mortality outcomes.
  • Follow-up for a minimum of 38 months or until death.

Main Results:

  • 46% of patients died during the follow-up period.
  • STAR grades 2-4 showed progressively increasing mortality; STAR grade 1 mortality was similar to grade 2.
  • STAR showed a trend toward superior mortality discrimination than GOLD (AUC 0.63 vs. 0.55), but BODEx was most accurate (AUC 0.70).

Conclusions:

  • The STAR system effectively stratified mortality risk in hospitalized COPD patients for grades 2-4.
  • STAR grade 1 did not effectively differentiate lower-risk patients.
  • STAR integration may enhance prognostic assessment, despite potential underestimation in some cases.